Photo of Samuel Blackman taken from Day One Biopharmaceuticals/LinkedIn
Feb 26, 2024, 11:23
Samuel Blackman shares the Day One journey to reshape pediatric cancer drug development – Day One Biopharmaceuticals
Day One Biopharmaceuticals shared on their LinkedIn:
“Head of R&D and co-founder Samuel Blackman shares the Day One journey to reshape pediatric cancer drug development in this article for the Pediatric Cancer Research Foundation’s Profectus blog, Turning ‘One Day’ into ‘Day One’.”
Proceed to the article.
Source: Day One Biopharmaceuticals/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 14:05
Nov 13, 2024, 12:13
Nov 13, 2024, 11:52
Nov 13, 2024, 11:48
Nov 13, 2024, 11:44
Nov 13, 2024, 11:39
Nov 13, 2024, 11:30
Nov 13, 2024, 11:25
Nov 13, 2024, 11:10